Thirteen patients with locally unresectable or metastatic melanoma were treated with immune checkpoint inhibitors, and 4 patients were initially treated with ipilimumab and switched to a PD-1 inhibitor after treatment failure. The gene discussed is PDCD1; the disease is metastatic melanoma.